Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial
Clinical trial NCT04647461 · UNKNOWN
Trial details
- NCT number
- NCT04647461
- Sponsor
- CHA University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2021-01-29
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.